PREVALENCE AND MANAGEMENT OF PATIENT-REPORTED SYMPTOMS ON STATIN THERAPY: INSIGHTS FROM THE PATIENT AND PROVIDER ASSESSMENT OF LIPID MANAGEMENT (PALM) REGISTRY

The definition of “statin intolerance” varies among patients and providers, with myalgia prevalence from 1-5% in clinical trials up to 29% in observational studies. The PALM Registry collected patient perspectives on statin-related symptoms and strategies used to continue treatment. We surveyed